Monday 8 October 2018

Breast Feeding Accessories Market Expected To Trigger A Revenue Increase To USD 2.4 Billion By 2025:Key Participant Medela LLC, Newell Brands

The Global Breast Feeding Accessories Market size is expected to reach USD 2.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 7.9% during the forecast period. Improving healthcare infrastructure in emerging economies and increasing number of milk banks are key factors driving the market. Moreover, growing awareness about the advanced breastfeeding accessories along with increasing number of working women in developing regions would boost the market demand.


As per the statistics provided by WHO, infant mortality has declined to a great extent, which would also fuel product demand. In addition, according to a report published by the U.S. CDC, infant mortality in U.S. declined by 15.0%. Thus, demand for breastfeeding accessories is expected to grow over the forecast period. The breastfeeding accessories market is comparatively mature in developed economies, such as U.S., Germany, France, and Australia, owing to presence of key companies in these countries and high demand for such products.
On the other hand, developing Asian and Latin American countries currently have a moderate adoption rate of these products due to lack of awareness. Economic growth and rising disposable income levels in these countries are anticipated to drive the market. Manufacturing companies are investing in such developing regions to expand their presence. This is also expected to augment market demand.
Full Research Report On breastfeeding accessories market Analysis:
www.grandviewresearch.com/industry-analysis/breastfeeding-accessories-market

Further key findings from the study suggest:
·         Nipple care products are projected to witness a remarkable CAGR of 8.9% over the forecast years owing to high adoption of nipple shields, especially in U.S.
·         Asia Pacific region is estimated to witness the highest CAGR of 10.7% during the estimated period due to increased adoption of pumping technology, rising disposable income levels, and increased number of working women
·         North America commanded over 53.0% share of the global breastfeeding accessories market in 2016 owing to sophisticated healthcare infrastructure and higher product awareness among consumers
·         Some of the key companies in the global market are Koninklijke Philips N.V., Medela LLC, Newell Brands, Ameda, Pigeon Corporation, Nuby, Mayborn Group Limited, Artsana S.p.A., Edgewell Personal Care, and Handi-Craft Company (Dr. Brown’s).
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global breastfeeding accessories market on the basis of product and region:
Breastfeeding Accessories Product Outlook (Volume, Units Sold; Revenue, USD Million, 2014 - 2025)
·         Nipple Care Products
·         Breast Shells
·         Breast Pads
·         Baby Scales
·         Breastmilk Preparation & Cleaning Products
·         Breastmilk Storage & Feeding
·         Other Accessories
Breastfeeding Accessories Regional Outlook (Volume, Units Sold; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    U.K.
o    Germany
o    France
o    Italy
o    Spain
o    Switzerland
o    Netherlands
o    Greece
·         Asia Pacific
o    Japan
o    China
o    India
o    Australia
o    Singapore
o    Malaysia
o    Russia
o    New Zealand
o    Vietnam
o    Hong Kong
·         Latin America
o    Brazil
o    Mexico
o    Argentina
o    Colombia
o    Costa Rica
·         Middle East & Africa
o    South Africa
o    Saudi Arabia
o    Oman
o    UAE
o    Egypt
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com

Sunday 7 October 2018

Women’s Health Therapeuticss Market Is Poised To Reach USD 210.9 Billion By 2025:Key Participant Teva Pharmaceutical Industries Ltd


San Francisco, 04 October 2018, The global women’s health therapeutics market size is expected to reach USD 210.9 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.8% over the forecast period. Entry of effective drugs, a rise in awareness about early diagnosis and treatment, along with prevalence of chronic diseases are among the key factors likely to drive the market during the forecast period.
The women’s health therapeutics market is expected to witness high growth in the forthcoming years due to increasing investment by key market players to fulfill demand in areas of infection, cancer, and pregnancy-related complications. In October 2016, Prelude Fertility, Inc. received USD 200 million from the Reproductive Biology Associates (RBA) and My Egg Bank North America (MEB) that focuses on providing fertility services and treatment to people with delayed childbirth. Juneau Biosciences, LLC has deployed USD 35 million until 2017 towards development of molecular diagnostics and therapeutics for endometriosis (uterus) conditions.
In January 2018, Melinta Therapeutics, Inc. acquired The Medicines Company’s infectious diseases business. This acquisition would help to the former expand its portfolio by offering life-saving treatment options. In November 2017, Biocon launched KRABEVA, a biosimilar used for the treatment of metastatic colorectal, cervical, ovarian, and brain cancer. Increasing investments by top market players are anticipated to propel the global market over the forecast period.
There is significant unmet need associated with treatment options for female sexual dysfunction. Currently, there are no Food and Drug Administration (FDA)-approved drugs for the treatment of female sexual dysfunction and many promising molecules are in late stage of development phase. Some of these molecules include LibiGel by BioSante Pharmaceuticals and Femprox by Apricus Bio, currently in Phase III and Phase II of clinical trials respectively in U.S.
Full Research Report On Women’s Health Therapeutics Market Analysis:
www.grandviewresearch.com/industry-analysis/womens-health-therapeutics-market


Further key findings from the report suggest:
·         By type, infection accounted for the largest market share in 2017 and is expected to maintain its dominance during the forecast period due to rising drug approvals, availability of diagnostic tests and treatments, and high incidence of infectious diseases
·         Ovarian cancer is anticipated to be the fastest-growing sub-segment of oncology during the forecast period due to high prevalence of ovarian cancer and approval of new and improved drugs
·         North America is expected to maintain its dominance in the coming years due to high awareness about women’s health, increase in number of advanced diagnostic and treatment methods, mergers and acquisitions by market players, and rise in infections and cancer cases
·         Asia Pacific is likely to witness significant growth over the next decade due to improving healthcare facilities, increase in commercialization and approval of products, and investment by market players
·         Some of the key players in women’s health therapeutics market are Bayer AG, Merck & Co., Pfizer, Teva Pharmaceutical Industries Ltd, AstraZeneca, Bristol-Myers Squibb (BMS) Company, Eli Lilly and Company, Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Mylan N.V., Sun Pharmaceutical Industries Ltd, and Sanofi.
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global women’s health therapeutics market based on type and region:
Women’s Health Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)
·         Infection
·         Pregnancy
·         Oncology
o    Cervical Cancer
o    Ovarian Cancer
o    Uterine Cancer
o    Vaginal & Vulvar Cancer
Women’s Health Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
o    France
o    Spain
o    Italy
·         Asia Pacific
o    China
o    Japan
o    India
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


Thursday 4 October 2018

Photoelectric Sensorss Market Expected To Trigger A Revenue Increase To USD 2.09 Billion By 2025:Key Participant Keyence Corporation


According to a report published by Grand View Research, Inc.; the photoelectric sensors market is expected to reach a valuation of around USD 2.09 billion by 2025.
Rising adoption of this sensors in various industrial end-use including manufacturing, packaging, and material handling industries can propel the market over the forecast period (2014 to 2025).
Various benefits associated with these sensors such as fast response time, long sensing distances, high resolution, cost effectiveness, extended operating life, low maintenance, and less power consumption are likely to boost their demand in different end-use in industries. Development and high adoption of industrial internet of things (IIoT) is also expected to positively drive the market growth in the years to come. These devices aid in improving operational efficiency and productivity in industries. Since, numerous industrial process systems depend on sensors to perceive reliable and accurate data to control and automation. IIoT mainly uses these sensors to measure pressures, positions, and several other important production parameters. Additionally, introduction of smart photoelectric sensors is likely to support the market growth during the forecast period. Use of these sensors provide several benefits including reduction in downtime, improved reliability, less maintenance cost, and reduced weight.

Full Research Report On Photoelectric Sensors Market Analysis: www.grandviewresearch.com/industry-analysis/photoelectric-sensors-market



Worldwide photoelectric sensors market can be segmented on the basis of technology, end-use, and region.
As per technology, the market can be characterized into diffused, thru-beam, and retro-reflective.
In 2016, the retro-reflective segment accounted for the major market share and expected to grow significantly. The technology offers efficient sensing of glossy and transparent objects, and small and large objects. It also comprises low installation and maintenance costs. The thru-beam segment is estimated to grow at a CAGR over 5.0%. The technology has capabilities like long sensing distances and stable operation. The diffused segment is expected to expand at a reasonable rate over the study period. Based on end-use, the market can be fragmented into automotive, electronics and semiconductor, military and aerospace, packaging, and others.

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/sensors-and-controls

The automotive segment dominated the market in 2016. These sensors are extensively used in sensing vehicles in parking lots, noticing shiny objects, and electronic power steering systems. The use of these sensors has increased in automobiles due to high implementation of emission guidelines. For instance, In Europe, the Euro 6 standards for exhaust emissions involves 56% reduction in nitrogen oxides emission for diesel engines. The packaging segment is likely to grow with the highest CAGR during the projected period. This growth can be associated with increasing automation and high adoption of these devices in packaging. These industries use these products for detecting transparent bottles, detection of wafers in vacuum conveyor system, and conveyor positioning control monitoring.
The military and aerospace segments, and electronics and semiconductor segment are projected to grow sensibly during 2017 to 2025. Increasing expenditure in military across several developed as well as emerging countries is likely to support the military and aerospace segment. Sensors are widely accepted in the military and aerospace sectors for detecting biological agent and surveillance.
Geographically, the market can be divided into North America, Europe, Asia Pacific, Central & South America, and Middle East and Africa.
In 2016, Asia Pacific estimated for around 35.0% of the overall market. The region is expected to grow at a CAGR of 6.0% over the forecast period. Increasing adoption of IIoT is various industrial facilities, growing technological advancements for improving operational efficiency, and rise in safety directives are likely to increase the demand for these sensors in the coming years. Rise in government regulations and industrial automation in emerging countries such as Japan, China, and India are expected to support6 the market growth in this region.
Europe is expected to grow on account of increasing implementation of strict guidelines for industrial automation in numerous manufacturing settings. The Middle East is also likely to observe promising demand due to existence of oil and gas companies in the region.
Major companies operating in the market include Rockwell Automation Inc.; Keyence Corporation; Panasonic Corporation; Schneider Electric SE; and Autonics Corporation.


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/

Neuroendoscopy Devicess Market Expected To Trigger A Revenue Increase To USD 203.9 Million By 2025:Key Participant B. Braun Medical Inc., Karl Storz


According to a report published by Grand View Research, Inc.; the Neuroendoscopy Devices Market is likely to reach a valuation of around USD 203.9 million by 2025.
Increasing cases of brain injuries and neural surgeries, and high demand for minimally invasive surgeries can propel the market over the forecast period (2014 to 2025). Additionally, increasing efforts from the government and private institutions to support the acceptance of neuroendoscopy and growing investments for research and development activities by the major players are expected to create positive outlook for the market.

Full Research Report On Neuroendoscopy Devices Market  Analysis: www.grandviewresearch.com/industry-analysis/neuroendoscopy-market


Conventional brain surgeries like craniotomy are mostly invasive and complex which involves complete opening of skull. These surgical procedures involve high risk of stroke or hemorrhage, deafness, blindness, and death in several cases. These conditions can be avoided by adopting minimally invasive procedures. Therefore, use of neuroendoscopy is increasing constantly. These devises are extensively used in the treatment of intraventricular hemorrhage and bleeding, hydrocephalus, and pituitary tumors. Thus, continuous rise in cases of pituitary tumors and intraventricular hemorrhage are likely to support the market growth in the coming years.
Worldwide neuroendoscopy devices market can be segmented on the basis of devices type, surgery, type, application, and region.

Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices

Based on devices type, the market can be classified into rigid and flexible.
Rigid segment is expected to show high growth in the years to come. Rigid neuroendoscopes are extensively used to treat disorders including hydrocephalus, intraventricular tumors, and cystic lesions. As per Hydrocephalus Association U.S., one to two of every 1000 babies born are diagnose with hydrocephalus. Therefore, high prevalence of these disorders is expected to drive the segment growth. These devices are available in light weight versions, therefore have high demand in interventricular surgeries. 

As per surgery type, the market can be bifurcated into intraventricular, transcranial, and transnasal. In 2016, Intraventricular segment estimated for the major revenue share owing to high prevalence of the intraventricular hemorrhage and bleeding. The, transcranial surgery segment is likely to display rapid growth during the forecast period due to technological developments and growing cases of pituitary gland tumors. On the basis of application, the market can be categorized into hospitals and medical research centers.

In 2016, the hospitals segment acquired the largest market share and likely to continue this trend over the forecast period. Several benefits offered by neuroendoscopy such as exact access at target site that is situated in the interior parts of brain and minimal incision have forced hospitals to adopt this procedure. Moreover, hospitals have reported the high number of neuro-endoscopic procedures due to availability of established healthcare facilities in case of emergencies and presence of skilled health care specialist and neurosurgeons.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America is largest markets followed by the Europe. In 2016, these regions collectively acquired the major market share due to availability of advanced healthcare infrastructure and high use of advanced techniques, which has lead to high adoption of neuroendoscopy. In addition, technological developments in the healthcare and high prevalence of pituitary tumors are supporting the market growth in these regions. The U.S is considered as the major market for neuroendoscopy across the globe. Fast recovery of patients operated with minimally invasive procedure offered by these devices has increased the popularity of these devices in the country.

Asia Pacific market is expected to show rapid growth during the forecast period due to presence of unexploited growth opportunities in the region. Countries such as India, China and Japan have huge opportunities. Factors such as enforced healthcare insurance, growing technological advancements, and growing healthcare spending are expected to boost the market growth in this region.
Key companies operating in the market include B. Braun Medical Inc.; Olympus Corporation; Stryker, Medtronic; and Karl Storz. Major participants in the market are trying to strengthen their position in the market by adopting strategies like mergers and acquisitions, and strategic alliances.


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/